BioRestorative Therapies (BRTX) Interest Coverage Ratio (2010 - 2025)
BioRestorative Therapies' (BRTX) quarterly Interest Coverage Ratio came in at 0.17 in Q4 2025, up 99.73% YoY from 0.08 in Q4 2024, and up 98.1% on a QoQ basis from 8.94 in Q2 2025.
BioRestorative Therapies (BRTX) Interest Coverage Ratio (2010 - 2025) Analysis & Trends
BioRestorative Therapies (BRTX) has 16 years of Interest Coverage Ratio data on file, last reported at 0.17 in Q4 2025.
- Quarterly Interest Coverage Ratio rose 99.73% year-over-year to 0.17 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 0.69 (up 98.99% YoY) and the FY2025 annual result came in at 0.69, down 76.48% from the prior year.
- Interest Coverage Ratio rose to 0.17 in Q4 2025, from 8.94 in the prior quarter.
- In the past five years, Interest Coverage Ratio ranged from a high of 0.17 in Q4 2025 to a low of 2687.42 in Q3 2024.
- A 5-year average of 267.39 and a median of 93.85 in 2022 frame the typical range for Interest Coverage Ratio.
- Annual changes were most pronounced in 2021 — Interest Coverage Ratio slumped 16708.62% — and 2025, when it surged 99.73%.
- Tracing BRTX's Interest Coverage Ratio over 5 years: stood at 101.26 in 2021, then slipped by 13.37% to 114.8 in 2022, then soared by 33.21% to 76.67 in 2023, then increased by 18.9% to 62.18 in 2024, then jumped by 99.73% to 0.17 in 2025.
- The last three Interest Coverage Ratio figures came in at 0.17 (Q4 2025), 8.94 (Q2 2025), and 8.49 (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.59 Bn | 131.73 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.21 Bn | 78.22 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 65.65 Bn | 60.47 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.67 Bn | 52.53 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 42.10 Bn | 37.00 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 31.62 Bn | 28.31 Bn | 992.69 Mn | 2.82 |
| 7 | BioNTech SE | 27.90 Bn | 9.51 Bn | 668.28 Mn | 76.86 |
| 8 | Insmed | 27.51 Bn | 26.35 Bn | 358.27 Mn | -0.08 |
| 9 | Royalty Pharma | 27.29 Bn | 26.45 Bn | - | 1.42 |
| 10 | BioRestorative Therapies | 1.94 Mn | -1.01 Mn | 17,964.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -0.17 |
| Jun 30, 2025 | -8.94 |
| Mar 31, 2025 | -8.49 |
| Dec 31, 2024 | -62.18 |
| Sep 30, 2024 | -2,687.42 |
| Jun 30, 2024 | -836.88 |
| Mar 31, 2024 | -31.66 |
| Dec 31, 2023 | -76.67 |
| Sep 30, 2023 | -189.96 |
| Jun 30, 2023 | -135.42 |
| Mar 31, 2023 | -137.57 |
| Dec 31, 2022 | -114.80 |
| Sep 30, 2022 | -93.85 |
| Jun 30, 2022 | -77.52 |
| Mar 31, 2022 | -123.92 |
| Dec 31, 2021 | -101.26 |
| Sep 30, 2021 | -7.44 |
| Jun 30, 2021 | -6.09 |
| Mar 31, 2021 | -380.24 |
| Dec 31, 2020 | -3.37 |